BIOINC Pitch-To-Portfolio Competition 2025
Revolutionary Single-Cell Technology Meets Investment Opportunity
We're Pitching Live-seq: The Future of Cell Analysis
The Mansfield Bio-Incubator represents the heart of Massachusetts' biotech innovation ecosystem, the perfect setting to showcase how Swiss precision meets American innovation through Cytosurge's Live-seq technology.
The Problem: Current single-cell analysis destroys samples, missing critical temporal dynamics in drug development and cell therapy manufacturing.
Our Solution: Live-seq enables repeated RNA sequencing from the SAME living cell, revealing how cells respond over time without destroying them.
The Impact:
- Accelerate drug discovery with real-time response monitoring
- Ensure cell therapy quality without sample loss
- Generate temporal data essential for AI-driven predictions
Eric will be on-site all day for:
- Technology demonstrations
- Partnership discussions
- Investment conversations
- Collaboration opportunities
We're excited to connect with investors, entrepreneurs, and fellow innovators advancing biotech, pharma, and life sciences.
See you in Mansfield!